secwatch.observer — SEC 8-K summary
======================================

Issuer:     Processa Pharmaceuticals, Inc. (PCSA)
CIK:        0001533743
Form:       8-K
Filed at:   2026-01-07T23:59:59+00:00
Accession:  0001493152-26-000733
Event type: regulatory
Sentiment:  positive
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Processa Pharmaceuticals regains compliance with Nasdaq $1.00 minimum bid price; delisting matter closed
--------------------------------------------------------------------------------

- Received Nasdaq notification on January 6, 2026 confirming compliance with Listing Rule 5550(a)(2).
- Company had previously been notified of bid price deficiency; now the deficiency is resolved.
- Nasdaq Capital Market continued listing is no longer at risk from bid price requirement.
- No other material changes; CEO George Ng signed the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533743/000149315226000733/0001493152-26-000733-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533743/000149315226000733/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-000733

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer